Advanced in Stroke

Robert G. Tieleman

Groningen, GR, NL 
Advanced in Stroke
Groningen, GR, NL 
OverviewLocationsClinical Research

Overview

Robert Tieleman practices in Groningen, Netherlands. Mr. Tieleman is rated as an Advanced expert by MediFind in the treatment of Stroke. His top areas of expertise are Atrial Fibrillation, Stroke, Heart Failure, Inappropriate Sinus Tachycardia (IST), and Cardiac Ablation.

His clinical research consists of co-authoring 90 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 28 articles in the study of Stroke.

Gender
Male

Locations

Groningen, GR, Netherlands
Other Locations
Maastricht, LI, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Prospective Randomized Multicenter Study of Flecainide Acetate Oral Inhalation Solution in Single and Repeat Dose Regimens for Acute Conversion to Sinus Rhythm in Subjects With Recent Onset of Symptomatic Paroxysmal Atrial Fibrillation
A Prospective Randomized Multicenter Study of Flecainide Acetate Oral Inhalation Solution in Single and Repeat Dose Regimens for Acute Conversion to Sinus Rhythm in Subjects With Recent Onset of Symptomatic Paroxysmal Atrial Fibrillation
Enrollment Status: Completed
Publish Date: May 14, 2024
Intervention Type: Drug
Study Drug: Flecainide Acetate
Study Phase: Phase 2
Clinical Investigation to Determine the Accuracy and Benefit of Cardioskin™ in Patients With Known Atrial Fibrillation
Clinical Investigation to Determine the Accuracy and Benefit of Cardioskin™ in Patients With Known Atrial Fibrillation
Enrollment Status: Withdrawn
Publish Date: May 07, 2021
Intervention Type: Device
Study Phase: Not Applicable
Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department (RACE 7 ACWAS-trial)
Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department (RACE 7 ACWAS-trial)
Enrollment Status: Completed
Publish Date: January 21, 2020
Intervention Type: Drug, Procedure
Study Phase: Not Applicable
View 2 Less Clinical Trials

90 Total Publications

Association between circulating biomarkers and atrial fibrillation burden in patients with paroxysmal atrial fibrillation: a subanalysis of the RACE V study.
Association between circulating biomarkers and atrial fibrillation burden in patients with paroxysmal atrial fibrillation: a subanalysis of the RACE V study.
Journal: Open heart
Published: May 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tieleman's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile